Welcome to
HabPharmaceuticals
LOADING
HAB Pharma offers contract manufacturing and CDMO services supported by over three decades of manufacturing experience and a well-established production network in India. With three WHO-GMP certified facilities and an annual production capacity of approximately 4.4 billion units, the company delivers consistent, large-scale manufacturing across multiple dosage forms.
Our approach combines formulation expertise, robust manufacturing processes, and regulatory alignment to support pharmaceutical partners from development through commercialization. Backed by an integrated R&D framework and proven technology transfer capabilities, HAB Pharma ensures that every product is developed for stability, scalability, and long-term market performance.
We operates as an integrated CDMO partner, supporting the complete product lifecycle from early-stage development to commercial manufacturing.
Development of stable and effective formulations, followed by seamless transfer to manufacturing with process consistency and scalability.
Validated analytical methods and structured quality systems ensure product integrity across all stages of development and manufacturing.
Robust manufacturing processes across multiple facilities enable efficient scale-up from pilot batches to commercial volumes.
Alignment with regulatory requirements through documentation, quality compliance, and coordinated project execution.
We offers a broad and integrated manufacturing base across key pharmaceutical dosage forms. R&D capabilities further extend into complex formulations, including modified release systems, enteric coatings, and specialized delivery platforms, supporting differentiated product development.
Our manufacturing network comprises three facilities located in Vasai, Mumbai, and Selaqui, Dehradun, operating across six production blocks with a workforce of over 600 professionals. The integrated network enables operational flexibility, efficient load distribution, and consistent production output across markets.
These facilities collectively support:
Quality is embedded across every stage of development and manufacturing at HAB Pharma, supported by WHO-GMP certified facilities and ISO 9001:2015 compliant systems. Our approach is guided by Quality by Design principles, ensuring that each formulation is developed with a strong foundation of consistency, stability, and performance from the outset. Structured quality assurance frameworks and robust documentation systems enable effective process control, maintaining alignment from R&D through to commercial production. This integrated model ensures reproducibility, regulatory readiness, and reliable manufacturing outcomes across all products.
HAB Pharma follows a structured development pathway designed to ensure smooth transition from concept to market:
Products manufactured by HAB Pharma are supplied to multiple international markets, including regions across:
HAB Pharma brings together a well-established manufacturing network with the scale and consistency required for reliable contract manufacturing. Our integrated CDMO approach connects formulation development, technology transfer, and commercial production within a single, aligned system, allowing for continuity across every stage of the product lifecycle. With capabilities spanning a wide range of dosage forms, including more complex formulations, we are equipped to support diverse product requirements. This is reinforced by a strong regulatory and quality framework that underpins all operations. Over the years, we have built experience in supplying to multiple international markets, enabling us to work effectively with partners across different regions and regulatory environments.
Collaborate with HAB Pharma for reliable, scalable, and quality-driven contract manufacturing solutions.
